Rusfertide (for reducing Hb/HCT) is making progress

[EPguy]

A small update on trials from Sept:

"...These data (various phase 2 trials) provide support for the ongoing, randomized phase 3 VERIFY trial (NCT05210790), which intends to enroll about 250 patients with PV who require frequent phlebotomy.."

targetedonc.com/view/rusfer...

This is the phase 3 trial. If you're having Hb/HCT troubles with current treatments you can discuss with Dr whether you're eligible and might benefit.

clinicaltrials.gov/ct2/show...

[hunter5582]

Rusfertide is a very promising step forward in PV treatment. It will hopefully prove superior to the chronic iron deficiency due to venesections. Glad to see some movement to Phase 3. I will be interested to see the specifics of who will qualify for this phase of the clinical trials. Rusfertide may prove very beneficial as a combination agent for people on other cytoreductive treatments. Thanks for posting the links.